Literature DB >> 16868705

25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance.

Hulya Taskapan1, Mingxin Wei, Dimitrios G Oreopoulos.   

Abstract

In terms of both exogenous sources (diet), and endogenous production (activation through exposure to ultraviolet light), vitamin D is unique. Few foods naturally contain vitamin D and only a few are fortified with vitamin D. Most people get more than 90% of their vitamin D requirements from exposure to sunlight. Those who protect their skin from ultraviolet-B radiation with clothing or sunscreen, the elderly, and dark-skinned individuals have limited capacity to produce vitamin D. Vitamin D deficiency is common in the general population and even more common in patients with chronic renal failure (CKD). Increased use of sun-blocking agents and decreased exposure to sunlight, to reduce the risk of skin cancer, attributed to exposure to UV radiation, may contribute to the increase in vitamin D deficiency in the population. These issues are particularly important in the dialysis population who are at particular risk because these, mostly elderly, individuals have an inactive life style and have reduced exposure to sunshine and UV light, thus limiting the actinic synthesis of vitamin D. The nephrology community seems to have overlooked the importance of vitamin D for overall health and well being in patients with CKD. Recently however, several authors have called attention to the role of plasma 25(OH)D3 levels in mineral metabolism dysregulation in patients with chronic kidney diseases, and those on dialysis. Vitamin D not only contributes to skeletal health but also plays a major role in the health of a wide variety of other organ systems. It seems that vitamin D supplementation is the most effective way of preventing vitamin D deficiency.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868705     DOI: 10.1007/s11255-006-0081-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  45 in total

1.  Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation.

Authors:  F C Garland; C F Garland; E D Gorham; J F Young
Journal:  Prev Med       Date:  1990-11       Impact factor: 4.018

Review 2.  How important is vitamin D deficiency in uraemia?

Authors:  J Cunningham; H Makin
Journal:  Nephrol Dial Transplant       Date:  1997-01       Impact factor: 5.992

3.  Effect of 1 alpha,25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions.

Authors:  E L Smith; N C Walworth; M F Holick
Journal:  J Invest Dermatol       Date:  1986-06       Impact factor: 8.551

4.  Response of uremic osteoid to vitamin D.

Authors:  D E Memmos; J B Eastwood; E Harris; A O'Grady; H E de Wardener
Journal:  Kidney Int Suppl       Date:  1982-05       Impact factor: 10.545

5.  Effects of vitamin D and parathyroid hormone on muscle: potential role in uremic myopathy.

Authors:  E Ritz; R Boland; W Kreusser
Journal:  Am J Clin Nutr       Date:  1980-07       Impact factor: 7.045

6.  Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables.

Authors:  M F Holick
Journal:  Fed Proc       Date:  1987-04

Review 7.  Interactions of 1,25-dihydroxyvitamin D3 and the immune system.

Authors:  S C Manolagas; D M Provvedini; C D Tsoukas
Journal:  Mol Cell Endocrinol       Date:  1985-12       Impact factor: 4.102

8.  1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60).

Authors:  H Tanaka; E Abe; C Miyaura; T Kuribayashi; K Konno; Y Nishii; T Suda
Journal:  Biochem J       Date:  1982-06-15       Impact factor: 3.857

9.  25-hydroxycholecalciferol stimulation of muscle metabolism.

Authors:  S J Birge; J G Haddad
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Shanna Nesby-O'Dell; Kelley S Scanlon; Mary E Cogswell; Cathleen Gillespie; Bruce W Hollis; Anne C Looker; Chris Allen; Cindy Doughertly; Elaine W Gunter; Barbara A Bowman
Journal:  Am J Clin Nutr       Date:  2002-07       Impact factor: 7.045

View more
  23 in total

Review 1.  Is 24,25(OH)D level really high in dialysis patients with high FGF23 levels?

Authors:  Hulya Taskapan
Journal:  Int Urol Nephrol       Date:  2012-03-31       Impact factor: 2.370

2.  Impact of vitamin D3 dietary supplement matrix on clinical response.

Authors:  Michael L Traub; John S Finnell; Anup Bhandiwad; Erica Oberg; Lena Suhaila; Ryan Bradley
Journal:  J Clin Endocrinol Metab       Date:  2014-03-31       Impact factor: 5.958

3.  Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism.

Authors:  Hulya Taskapan; Reinhold Vieth; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2008-06-05       Impact factor: 2.370

4.  Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.

Authors:  Sylvie Dusilová-Sulková; Roman Šafránek; Jaroslava Vávrová; Jiří Horáček; Ladislava Pavlíková; Vladimír Palička
Journal:  Int Urol Nephrol       Date:  2014-09-28       Impact factor: 2.370

5.  Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease.

Authors:  Sylvie Dusilova Sulkova; Jiri Horacek; Pavel Zivny; Pavla Rehorkova; Miloslav Podhola; Mirko Kadlec; Ctibor Povysil
Journal:  Int Urol Nephrol       Date:  2010-05-07       Impact factor: 2.370

Review 6.  The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes.

Authors:  Gerardo Sarno; Giuseppe Daniele; Giacomo Tirabassi; Alberto O Chavez; Opeolu O Ojo; Francesco Orio; Hana Kahleova; Giancarlo Balercia; William B Grant; Paride De Rosa; Annamaria Colao; Giovanna Muscogiuri
Journal:  Endocrine       Date:  2015-05-22       Impact factor: 3.633

7.  Vitamin D deficiency, insulin resistance, serum adipokine, and leptin levels in peritoneal dialysis patients.

Authors:  Ozkan Ulutas; Hulya Taskapan; Mehmet Cagatay Taskapan; Ismail Temel
Journal:  Int Urol Nephrol       Date:  2012-10-12       Impact factor: 2.370

8.  Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations.

Authors:  Josée Bouchard; Denis Ouimet; Michel Vallée; Jean-Philippe Lafrance; Martine Leblanc; Lyne Sénécal; Alain Bonnardeaux; Jean-Pierre Mathieu; Vincent Pichette
Journal:  Int Urol Nephrol       Date:  2008-12-05       Impact factor: 2.370

9.  Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients.

Authors:  Garip Sahin; Ismail Kirli; Basar Sirmagul; Ertugrul Colak; Ahmet Ugur Yalcin
Journal:  Int Urol Nephrol       Date:  2009-04-29       Impact factor: 2.370

10.  Spontaneous and simultaneous rupture of both Achilles tendons and pathological fracture of the femur neck in a patient receiving long-term hemodialysis.

Authors:  Kemal Ureten; Mehmet Akif Oztürk; Mustafa Ozbek; Selman Unverdi
Journal:  Int Urol Nephrol       Date:  2008-08-08       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.